Zymeworks (ZYME) Exchange Rate Effect (2021 - 2026)
Zymeworks recorded quarterly Exchange Rate Effect of $98000.0 in Q1 2026, up 322.73% quarter-over-quarter from -$44000.0 in Q4 2025, and up 880.0% year-over-year from $10000.0 in Q1 2025.
Zymeworks' Exchange Rate Effect history runs 6 years deep, the most recent figure standing at $98000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 880.0% year-over-year to $98000.0; the TTM figure through Mar 2026 stood at $43000.0 (down 75.71% YoY), while the FY2025 annual figure was -$45000.0, down 115.73% from the prior year.
- Exchange Rate Effect came in at $98000.0 for Q1 2026 at Zymeworks, up from -$44000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $346000.0 in Q1 2023 to a low of -$123000.0 in Q1 2022.
- A 5-year average of $52705.9 and a median of $23000.0 in 2023 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect surged 3866.67% in 2024 and tumbled 241.94% in 2025, its largest moves.
- Zymeworks' Exchange Rate Effect stood at -$88000.0 in 2022, then jumped by 96.59% to -$3000.0 in 2023, then soared by 3866.67% to $113000.0 in 2024, then slumped by 138.94% to -$44000.0 in 2025, then jumped by 322.73% to $98000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $98000.0, -$44000.0, and $77000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | 98,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98,000.00 |
| Mar 31, 2026 | 98,000.00 |
| Dec 31, 2025 | -44,000.00 |
| Dec 31, 2025 | -44,000.00 |
| Sep 30, 2025 | 77,000.00 |
| Sep 30, 2025 | 77,000.00 |
| Jun 30, 2025 | -88,000.00 |
| Jun 30, 2025 | -88,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 113,000.00 |
| Dec 31, 2024 | 113,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Jun 30, 2024 | 62,000.00 |
| Mar 31, 2024 | 119,000.00 |
| Mar 31, 2024 | 119,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Jun 30, 2023 | -12,000.00 |
| Jun 30, 2023 | -12,000.00 |
| Mar 31, 2023 | 346,000.00 |
| Mar 31, 2023 | 346,000.00 |
| Dec 31, 2022 | -88,000.00 |
| Dec 31, 2022 | -88,000.00 |
| Sep 30, 2022 | 248,000.00 |
| Sep 30, 2022 | 248,000.00 |
| Jun 30, 2022 | 166,000.00 |
| Jun 30, 2022 | 166,000.00 |
| Mar 31, 2022 | -123,000.00 |
| Mar 31, 2022 | -123,000.00 |
| Dec 31, 2021 | 105,000.00 |
| Dec 31, 2021 | 105,000.00 |